14633-17-1Relevant articles and documents
Novel pyrrolidine or piperidine derivatives having activity for T-type calcium channel
-
Paragraph 0203-0206, (2020/04/23)
A pyrrolidine or piperidine compound having activity for T - type calcium channel, wherein the pyrrolidine or piperidine compound of Formula 1 according to the present invention has an excellent antagonistic activity to, T-type calcium channel, and can be used as a preventive or therapeutic agent, for pain diseases, or cancer related to cancer, or cancer such as, epilepsy and,hepatic pain, angina. (by machine translation)
HYDROXYL PURINE COMPOUNDS AND USE THEREOF
-
Paragraph 0151; 0152; 0153; 0154, (2018/04/05)
Disclosed are a series of hydroxyl purine compounds and the use thereof as PDE2 or TNFα inhibitors, in particular, the compounds as shown in formula (I), or tautomers thereof or pharmaceutically acceptable salts thereof.
RETROVIRAL PROTEASE INHIBITING COMPOUNDS
-
, (2008/06/13)
A retroviral protease inhibiting compound of the formula: STR1 is disclosed wherein R 1, R 2, R 5, R 6, Y m and Y' n are herein defined.